CHOICE connects to a wider landscape of ongoing BRCA research:

• BRCA-PREVENT (ERC, 2023 to 2025): working to establish consensus on new approaches to prevention for women carrying BRCA1 mutations.
• 4D PICTURE (Horizon Europe, 2022 to 2027): building digital tools that combine patient experience data with clinical information to support personalised cancer care.
• CINDERELLA (Horizon Europe, 2022 to 2026): exploring how AI-generated simulations of surgical outcomes can help breast cancer patients and their doctors make treatment decisions together.
• Europe’s Beating Cancer Plan: CHOICE contributes to and aligns with this broader EU policy initiative.

This section will be updated regularly with relevant new research and developments in BRCA care.